OUR MAY ISSUE IS NOW LIVE
 
Urology Times cover
View the latest issue online.
Study shows benefit of adjuvant chemo after nephroureterectomy
"This important trial supports the use of adjuvant chemotherapy after nephroureterectomy for stage T2 or higher cases," writes Badar M M. Mian, MD.
Read his column
 
CARES Act: Here’s what physicians should know
The bill provides coverage of nonreimbursable expenses attributed to COVID-19, writes Jeff Witz, CFP.
Learn more
 
 
 
MORE FROM UROLOGY TIMES:
 
53% of CIS patients achieve complete response with nadofaragene
Study adds to evidence linking anticholinergics, dementia